Pfizer
Boris Braylyan is an accomplished professional with extensive experience in information management and regulatory systems within the pharmaceutical industry, primarily at Pfizer since April 2005. Currently serving as Vice President of Information Management - Operations Center of Excellence, Boris is responsible for enterprise governance, portfolio management, and strategic direction across Development Operations, Regulatory, and Safety domains. Notable past roles include Senior Director of Regulatory Information Management, where Boris established organizational structures, managed performance, and fostered partnerships for effective regulatory systems. Boris's career also includes leadership positions focused on enterprise content management and software architecture at RTS, LLC and CYA Technologies, showcasing a strong expertise in project architecture, technical direction, and vendor relationships. Boris holds an MBA from Rensselaer at Work and a Bachelor’s degree in Computer Science and Engineering from the University of Connecticut.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.